A Sept. 8 clinical review turns a complicated testing issue into one household habit: keep the medication, timing and preparation context beside the lab result.
A new Medicare Advantage study points to a hidden health-system problem: a plan that feels simple while you are healthy can become complicated after the diagnosis changes.
FDA added a boxed warning to ferric carboxymaltose injection this week. The broader household lesson is to attach a follow-up question to every treatment plan.
Heart experts say cognition and frailty belong in the cardiovascular picture. Your 12-minute move is recording one safe daily function before normal drifts.
BioNTech terminated a Phase 2 colorectal-cancer trial after independent review. The household skill is learning why a study stopped before deciding what the headline means.
